Name: Peter Papenhausen
Title: National Director of Cytogenetics, Laboratory Corporation of America
NEW YORK (GenomeWeb News) – Two new loci have been linked to elevated risk for a childhood embryonal kidney cancer called Wilms tumor, according to a study appearing online yesterday in Nature Genetics.
Using custom microarrays and bisulfite sequencing, researchers have garnered evidence of extensive shifts and variability in methylation patterns in the genomes of several types of cancers.
Biovista will use its Clinical Outcomes Search Space platform to identify new treatments as part of the EU's "p-medicine" project.
The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.
A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.
The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.
In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.